Aytu Biopharma (AYTU) Gross Profit Growth (3y) (2017 - 2026)
Powered by 
Analysis
Aytu Biopharma (AYTU) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.24 Bn | 623.49 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 443.24 Bn | 436.67 Bn | 12.70 Bn | 9.68% |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | 3.51% |
| 4 | Novartis Ag | 266.33 Bn | 258.64 Bn | 11.24 Bn | 10.19% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 3.85% |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn | 10.15% |
| 7 | Revolution Medicines | 44.03 Bn | 44.03 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.82 Bn | 1.57 Bn | 20.97% |
| 9 | United Therapeutics | 21.58 Bn | 18.92 Bn | 683.80 Mn | 8.70% |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -15.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -15.83% |
| Dec 31, 2025 | -17.75% |
| Sep 30, 2025 | -20.13% |
| Jun 30, 2025 | -11.60% |
| Mar 31, 2025 | 0.31% |
| Dec 31, 2024 | -4.28% |
| Sep 30, 2024 | -1.28% |
| Jun 30, 2024 | -0.73% |
| Dec 31, 2023 | 17.96% |
| Sep 30, 2023 | 11.30% |
| Jun 30, 2023 | 24.76% |
| Mar 31, 2023 | 27.44% |
| Dec 31, 2022 | 88.81% |
| Sep 30, 2022 | 156.85% |
| Jun 30, 2022 | 140.52% |
| Mar 31, 2022 | 93.13% |
| Dec 31, 2021 | 113.16% |
| Sep 30, 2021 | 130.22% |
| Jun 30, 2021 | 154.68% |
| Dec 31, 2020 | 137.30% |